Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Cipla
Argus Health
Johnson and Johnson
Cantor Fitzgerald
AstraZeneca
Merck
US Army
Cerilliant

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020098

« Back to Dashboard

NDA 020098 describes MIVACRON, which is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. Additional details are available on the MIVACRON profile page.

The generic ingredient in MIVACRON is mivacurium chloride. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the mivacurium chloride profile page.
Summary for 020098
Tradename:MIVACRON
Applicant:Abbvie
Ingredient:mivacurium chloride
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020098
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER mivacurium chloride INJECTABLE;INJECTION 020098 NDA AbbVie Inc. 0074-4365 N 0074-4365-05
MIVACRON mivacurium chloride SOLUTION;INTRAVENOUS 020098 NDA AbbVie Inc. 0074-4365 N 0074-4365-05

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;INTRAVENOUSStrengthEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jan 22, 1992TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 0.5MG BASE/ML
Approval Date:Jan 22, 1992TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 50MG BASE/100ML
Approval Date:Jan 22, 1992TE:RLD:No

Expired US Patents for NDA 020098

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie MIVACRON mivacurium chloride SOLUTION;INTRAVENOUS 020098-001 Jan 22, 1992 ➤ Sign Up ➤ Sign Up
Abbvie MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER mivacurium chloride INJECTABLE;INJECTION 020098-002 Jan 22, 1992 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Cantor Fitzgerald
Moodys
Dow
Citi
Merck
Boehringer Ingelheim
Fish and Richardson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.